SCHEMBL4174882

SCHEMBL4174882

Cc1ccc(C(=O)N2CCC(c3ccc(CS(=O)(=O)O)cc3)CC2)cc1NS(C)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FASN P49327 19/20 0.58
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4175605 0.93 FASN (0.56) FASNNPC1
SCHEMBL4176497 0.91 FASN (0.58) FASN
SCHEMBL4176216 0.90 FASN (0.57) FASN
SCHEMBL4190006 0.88 FASN (0.55) FASN
SCHEMBL4176863 0.88 FASN (0.55) FASN
SCHEMBL4184616 0.88 FASN (0.61) FASN
SCHEMBL4174463 0.87 FASN (0.54) FASN
SCHEMBL4170791 0.87 FASN (0.60) FASN
SCHEMBL4182773 0.87 FASN (0.54) FASN
SCHEMBL4186690 0.87 FASN (0.54) FASNNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105305-A1 Therapeutic Agents - 550 ASTRAZENECA AB (SE) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105305-A1 Therapeutic Agents - 550 FABP4, GPR119, FASN FASN 3/4885NPC1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.